Mass General Brigham President and CEO Anne Klibanski Named as One of Modern Healthcare’s Most Influential People

Modern Healthcare has named Mass General Brigham president and CEO Anne Klibanski, MD, as one of the 100 Most Influential People in Healthcare for 2024. The complete rankings can be found in the December 9 issue of Modern Healthcare magazine, and profiles of all the honorees are available online on Modern Healthcare’s website.

This recognition acknowledges individuals who are deemed by their peers and the senior editors of Modern Healthcare to be the most influential figures in the industry in terms of leadership and impact.

Appointed to her role in 2019, Dr. Klibanski’s vision for Mass General Brigham is to build the most impactful, patient-focused, and equitable academic healthcare system in the world, delivering the highest-quality research-infused care that improves outcomes for all. Dr. Klibanski is leading efforts to integrate Mass General Brigham’s clinical and academic services to enhance patient access and strengthen collaborations across the organization’s four-part mission of patient care, research, education, and commitment to community. Under her leadership, Mass General Brigham launched For Every Patient, its first-ever unified strategy to raise the bar for quality care across the organization. She has overseen increased investment in leading-edge research that has the potential to revolutionize treatments, such as gene and cell therapy, leveraging the system’s $2.4 billion in annual research funding. The system’s innovation team has created more than 300 companies that are making broad impacts on human health, in various spaces — from therapeutics to diagnostics and research.

Through her leadership, Mass General Brigham has invested significant resources to community health and has established United Against Racism, a long-term multi-year commitment to address the impacts that racism has on Mass General Brigham patients, employees, and the broader community.

Dr. Klibanski previously served as Chief Academic Officer at Mass General Brigham from 2012 to 2019 and as Chief of Neuroendocrine at Massachusetts General Hospital. She is recognized internationally for her high-impact research in neuroendocrine disorders and pituitary tumors.